Landmark Court Ruling In UK Could Pave Way For Cheaper, Generic PrEP

Photo courtesy of BigStock/Mbruxelle
Photo courtesy of BigStock/Mbruxelle

Photo courtesy of BigStock/Mbruxelle

GayStarNews reports that Britain’s High Court today ruled to overturn pharmaceutical company Gilead Science’s patent extension on Truvada, the HIV medication also used for PrEP (Pre-Exposure Prophylaxis) which, when taken as advised, stops HIV negative people acquiring HIV.

Read the full story at GayStarNews

Lavender Magazine

5100 Eden Ave, Suite 107 • Edina, MN 55436 • 612.436.4660

©2022 Lavender Media, Inc.